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ABSTRACT: To determine whether nocturnal hypoxaemia contributes to the excessive
erythrocytosis (EE) in Andean natives, standard polysomnographies were performed
in 10 patients with EE and in 10 controls (mean haematocrit 76.6¡1.3% and
54.4¡0.8%, respectively) living at an altitude of 4,380 m. In addition, the effect of O2
administration for 1 h prior to sleep, and the relationship between the hypoxic/
hypercapnic ventilatory response and the apnoea/hypopnoea index (AHI) during sleep
were studied.
Awake arterial oxygen saturation (Sa,O2) was significantly lower in patients with
EE than in controls (83.7¡0.3% versus 85.6¡0.4%). In both groups, the mean Sa,O2
significantly decreased during sleep (to 80.0¡0.8% in EE and to 82.8¡0.5% in
controls). The mean Sa,O2 values remained significantly lower in patients with EE than
in controls at all times of the night, and patients with EE spent significantly more time
than the controls with an Sa,O2 ofv80%. There were no differences between the two
groups in the number and duration of the apnoeas/hypopnoeas. None of these variables
were affected by O2 administration. In both groups the AHI positively correlated with
the hypercapnic ventilatory response.
Andean natives undergo minor respiratory disorders during sleep. The reduction
in oxygen saturation found in subjects with excessive erythrocytosis was small, yet
consistent and potentially important, as it remained below the threshold known for
the increase in erythropoietin stimulation. This may be an important factor promoting
erythropoiesis, but its relevance needs to be further explored.
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Excessive erythrocytosis (EE) and hypoxaemia are the
major features of a syndrome known as "chronic moun-
tain sickness" (CMS) [1, 2] affecting millions of highlanders
around the world and particularly common among Andean
natives. The pathogenesis of EE is still unclear. In fact, while
the increased erythropoiesis in highlanders is considered a
mechanism of adaptation to the hypoxic environment, it is
not clear why some of these subjects develop EE. One possible
explanation is that a blunted hypoxic ventilatory response
observed in highlanders with EE may induce a chronic
hypoventilation that worsens the hypoxaemia [3]. Other
authors have suggested that sleep-related hypoxaemia may
be the cause of EE [2, 4]. This suggestion is based on the
observation that hypoventilation is a physiological feature of
the sleep state at sea-level as well [5]. In addition, substantial
nocturnal hypoxaemia has been reported in highlanders at
3,100 m and 3,658 m [6, 7] and sleep-disordered breathing
(SDB) is a common finding in lowlanders ascending to high
altitude [8–10]. COOTE and co-workers [11, 12] were the first
to perform sleep studies in healthy Andean natives above
4,000 m and to determine the presence of nocturnal periodic
breathing associated with a moderate fall in arterial oxygen
saturation (Sa,O2). This finding led these authors to emphasise
the importance of studying the nocturnal respiratory pattern
in detail in these subjects. This should allow definitive
conclusions to be drawn about the importance of nocturnal
hypoventilation and/or SDB in the development of poly-
cythaemia. However, to date, a comparison of the nocturnal
respiratory profile between Andean highlanders with and
without EE has never been performed.
Therefore, the frequency and duration of nocturnal apnoea/
hypopnoea episodes, oxygen saturation, and sleep parameters
in a group of patients with EE were compared with a group of
controls that were permanent residents in the Andean town of
Cerro de Pasco (Peru) at an altitude of 4,380 m.
The occurrence of SDB at altitude could be related to an
altered hypoxic and/or hypercapnic ventilatory response [10,
13, 14]. However, the ventilatory control of lowlanders during
acute exposure to altitude is markedly different from that
found in altitude natives [3, 15]. Therefore, in order to investi-
gate a possible correlation between the hypoxic/hypercapnic
ventilatory response and the presence of SDB in the subjects,
the ventilatory response to isocapnic hypoxia and to
normoxic hypercapnia was assessed by classic rebreathing
manoeuvres.
Finally, in a preliminary report, it was suggested, at least
during wakefulness, that the depressed ventilation described
in patients with EE may be reversed by the acute (1 h)
administration of O2 [15]; similarly, a recent study showed an
increase in ventilation during O2 administration in similar
patients [16]. These previous references thus provided a
rationale for testing whether the 1-h administration of O2
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prior to sleep could improve oxygen saturation (and conse-
quently sleep parameters) during the night.
Methods
Subjects
The experiments were conducted in the Andean town
of Cerro de Pasco, Peru, at an altitude of 4,380 m, during
September 1–28, 2001. Two groups (EE and controls) of 10
subjects were selected for this study, on the basis of their
haematocrit (Ht) and haemoglobin (Hb). The values for
establishing the presence of EE were chosen according to
studies from LEON-VELARDE and co-workers [17, 18] who
measured Hb in the population of Cerro de Pasco and found
a 95 percentile of 21.3 g?dL-1, which corresponds to a Ht of
y64%. The SD of Ht and Hb in the healthy middle-aged male
population in Cerro de Pasco is 3.13% and 1.21 g?dL-1,
respectively [19]. Therefore, the EE group was comprised
of those subjects with an Ht of o70% and Hb of
o22.5 mg?dL-1, and the control group of subjects with an
Ht f60% and Hb f19.5 mg?dL-1. Two groups of 10 subjects
were established with these characteristics and provided a
chance of o99% for detecting significant differences in these
variables. All the subjects were selected from the male
population of Cerro de Pasco among those who fulfilled
these criteria. All subjects were Mestizos who were born and
had lived their life at that altitude (no visit to a lower altitude
in the last 12 months) and none of them was employed as a
miner. The characteristics of the subjects are shown in table 1.
Lung function was assessed by performing a standard flow/
volume spirometric curve with a Microlab 3500 (Sensormedics,
Milan, Italy). The calibration of the pneumotachygraph was
checked by a known air volume by a calibrated syringe. The
CMS score was assessed by a previously described [17]
questionnaire on clinical symptoms and signs (table 1).
Study protocol and polysomnography
All subjects underwent two consecutive nights of standard
polysomnography in Cerro de Pasco, in the "Laboratorio del
Instituto de Investigaciones de la Altura" of the Universidad
Peruana Cayetano Heredia of Lima, Peru. In the first night of
the study, the polysomnography was performed under basal
conditions while in the second night O2 was administered by
a facial mask for 1 h prior to sleep. For each patient the O2
flow was regulated in order to maintain Sa,O2 above sea-level
values (w96%). Polysomnographic recordings were performed
using a Compumedics P-Series, 18-channel sleep recorder
(Abbotsford, Victoria, Australia) with a standard set-up
according to the American Sleep Disorders Association [20].
Sleep stages were identified by electroencephalogram (EEG;
C3/A2 and C4/A1), electro-oculogram and by a bipolar
submental electromyogram (EMG); all recordings were
obtained from surface electrodes. Thoracic and abdominal
excursions were detected by inductance plethysmographic
bands. Airflow was detected by a nasal-oral thermocouple
and Sa,O2 by a finger pulse oximeter. The electrocardiogram
was monitored from precordial leads. Sleep stages were
scored according to RECHTSCHAFFEN and KALES [21]. Sleep
efficiency was defined as the total sleep time (TST) divided by
total registration time. Arousals were defined as an EEG shift
in the a or h frequency having a duration ofw3 s associated
with an increase in chin EMG [22]. Arousal index was defined
as the number of arousals?h sleep-1. Apnoeas and hypopnoeas
were defined as a complete cessation or aw50% decrease in
airflow, respectively, for o10 s, associated with a decrease in
Sa,O2 of o3%. Obstructive apnoeas were distinguished from
central apnoeas by the presence of respiratory effort (thoracic/
abdominal excursions). The apnoea/hypopnoea index (AHI)
was defined as the number of apnoeas or hypopnoeas per
hour of sleep according to standard definitions [20]. The drop
in Sa,O2 (DSa,O2) during each apnoea/hyperpnoea episode was
measured and averaged for the whole study period and is
labelled mDSa,O2. The mean Sa,O2 during 10 min of recording
before sleep was defined as "awake Sa,O2". The average of the
Sa,O2 during the whole sleep time is defined as "mean sleep
Sa,O2".
Hypoxic and hypercapnic ventilatory response
On the first and second study day, in order to determine the
hypoxic (HVR) and the hypercapnic ventilatory response
(HCVR), the subjects were studied in the seated position (in
the morning at rest for o2 h, and o2 h after a light breakfast
with no tea or coffee), and connected to a rebreathing circuit
through a mouthpiece, as previously described [23–25]. To
assess the response to progressive hypoxia, end-tidal carbon
dioxide (ETCO2) was kept constant by passing a portion of
the expired air into a scrubbing circuit before returning it
to the rebreathing bag. Conversely, when the response to
progressive hypercapnia was tested, O2 was continuously
supplied to the rebreathing circuit in order to maintain Sa,O2
at sea-level normoxic levels (w95%). The rebreathing tests
terminated when Sa,O2 reached 70% (hypoxic response) or
when ETCO2 reached 7.3 kPa (55 mmHg; hypercapnic
response). ETCO2 was continuously monitored by COSMO-
plus (Novametrix, Wallingford, CT, USA) connected to a
mouthpiece, and Sa,O2 by a 3740 Ohmeda Pulse Oximeter
(Ohmeda, Englewood, CO, USA). The COSMOplus was
precalibrated against known gas mixtures. The airway flow
was continuously measured by a Fleish pneumotachygraph
(Metabo Epalinges, Lausanne, Switzerland), connected to a
differential pressure transducer (RS part N395-257; RS
Components Ltd, Corby, UK) connected in series in the
expiratory part of the rebreathing circuit. The calibration
of the pneumotachygraph was checked before and after
each rebreathing manoeuvre. All signals were acquired on a
Macintosh personal computer (G3 model; Apple, Coupertino,
CA, USA) at the frequency of 300 per sample channel.
The respiratory flow signal was integrated by software, and
each breath was identified by an automatic and interactive
program. Breathing rate, tidal volume, and minute ventilation
(V9E) relative to each breath were recognised with their
corresponding values of Sa,O2 and ETCO2. The chemoreflex
Table 1. – Demographic, clinical and haematological data of
the subjects
EE Controls p-value
Age yrs 38.9¡2.5 38.5¡1.4 NS
BMI kg?m-2 23.3¡0.2 23.4¡0.8 NS
Haematocrit % 76.6¡1.3 54.4¡0.8 v0.0001
Haemoglobin g?dL-1 23.5¡0.3 16.9¡1.0 v0.0001
Red blood cells6109?L-1 7.4¡0.1 5.5¡0.1 v0.0001
CMS score 23.8¡3.3 10.3¡3.2 v0.0001
FVC L 4.43¡0.80 4.55¡0.54 NS
FEV1 L 3.52¡0.65 3.80¡0.44 NS
Data are presented as mean¡SEM unless otherwise stated; BMI:
body mass index; CMS: chronic mountain sickness; FVC: forced
vital capacity; FEV1: forced expiratory volume in one second; NS:
nonsignificant.
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sensitivity to hypoxia or hypercapnia was obtained from the
slope of the linear regression of V9E versus Sa,O2 or ETCO2,
respectively [23–25].
Statistical analysis
Differences between groups were analysed using the
unpaired t-test or the Mann-Whitney U-test. Differences
between groups and sleep and respiratory variables in the two
groups and by effects of O2 administration were also tested
by mixed-design analysis of variance. Data are presented as
mean¡SD. Linear regression was used to assess correlations
between parameters.
Results
Demographic characteristics of the subjects with haema-
tological and clinical data are shown in table 1. No significant
difference was observed in the lung function of the two
groups (table 1). The mean slopes of the HCVR were similar
in EE and controls, whereas the HVR slopes were slightly
lower in EE than in controls, but the difference was not
significant (HVR -0.43¡0.07 L?min-1?%Sa,O2
-1 and -0.67¡
0.1 L?min-1?%Sa,O2
-1 for EE and controls, respectively; HCVR
1.31¡0.16 L?min-1?mmHg CO2
-1 and 0.97¡0.1 L?min-1?mmHg
CO2
-1 for EE and control, respectively).
Sleep variables
During the first study night no significant differences were
observed in the TST, sleep efficiency, stages II, III, IV and
rapid eye movement (REM) sleep, and the arousal index
between the EE and the controls (table 2). Only stage I of
sleep was slightly longer in the controls. The arousal index
did not correlate with any of the haematological, clinical,
demographic or polysomnographic variables of the subjects.
For both groups all sleep variables remained unchanged
during the second night of the study, in which O2 was
administered for 1 h before sleep (table 2).
Respiratory variables during wakefulness and sleep
During wakefulness, patients with EE had a significantly
lower Sa,O2 compared with controls (83.7¡0.3% versus
85.6¡0.4%, pv0.01). In both groups, the mean values of
Sa,O2 significantly decreased, by a similar small extent during
sleep (to 80¡0.8% in EE and to 82.8¡0.5% in controls,
pv0.05; fig. 1). At all times of the night, the mean Sa,O2 values
remained significantly lower in EE than in controls (fig. 1).
The percentage of time that the two groups spent at various
Sa,O2 per cent ranges is shown in figure 2. Although both
groups spentw50% of the time in the Sa,O2 range 81–85%, the
controls spent more time than EE subjects with an Sa,O2 of
w80%, whereas EE subjects spent more time than the controls
with an Sa,O2 of v80% (y38% of the night in the range
76–80%). Since the TST was the same for both groups, the
same findings would be observed if the data were evaluated in
terms of actual time spent at each level of Sa,O2, rather than
in terms of percentage. Overall, the subjects with EE spent
10,343¡1,856 s (i.e. nearly 3 h) between 76–80% Sa,O2,
whereas the controls spent 3,039¡1,543 s (only y50 min) in
the same Sa,O2 range (pv0.01).
In both EE and controls, REM sleep was not associated
with episodes of marked hypoventilation and the lowest Sa,O2
levels reached were similar during non-REM and REM sleep
(table 3).
Both groups exhibited recurrent episodes of periodic
breathing characterised mainly by hypopnoeas alternated
with hyperpnoeas (fig. 3), while frank central apnoeas were
more rare. In only one patient with EE obstructive apnoeas
were present. The values of AHI, duration of hypopneas and
mDSa,O2 were similar in the two groups (table 3). With an
AHI ofy10, the severity of the sleep disorder could be defined
as "mild", according to the standard criteria for sea level [26].
The AHI showed a fair correlation with subjects9 age (r2=0.22,
pv0.05) and, more consistently, with the slope of HCVR
(r2=0.59, pv0.05) but not with the slope of HVR. Adminis-
tration of O2 prior to sleep in the second night of the study
did not alter any of these respiratory parameters (table 3).
Discussion
The new findings of this study are that Andean high-
altitude natives, with or without EE, undergo mild respiratory
disorders during sleep, and that subjects with EE have a
slightly, but highly consistent, lower nocturnal Sa,O2 and
spend significantly more time than controls with an Sa,O2 of
v80% during the night. These mild respriatory abnormalities
were not affected by 1-h administration of O2 prior to sleep.
In contrast to the many studies on SDB in lowlander
visitors to altitude, very few studies have addressed the
question of breathing during sleep in high-altitude natives,
particularly in those with EE. This study clearly indicates that
in Andean natives the occurrence of SDB among patients
with EE is similar to high-altitude natives with relatively
normal haematocrit in terms of frequency and duration of the
periodic breathing. However, although the absolute extent
Table 2. – Sleep variables recorded during the first night (basal) and second night (after oxygen administration) night in
excessive erythrocytosis (EE) and in controls
Basal EE After oxygen EE Basal controls After oxygen controls
TST min 333¡15 348¡14.5 312¡20.7 335¡13
Sleep efficiency % 79.4¡3.5 83.8¡3.1 74.4¡4.9 81.3¡3.2
Stage 1 (% of TST) 5.2¡0.7 4.2¡1.3 9.3¡1.4 7.2¡1.6
Stage 2 (% of TST) 55.6¡4.2 49.6¡5.2 50.9¡3.7 55.4¡3.9
Stage 3 (% of TST) 25.5¡3.1 26.0¡4.4 17.5¡2.1 18.7¡1.9
Stage 4 (% of TST) 8.8¡2.1 8.4¡2.0 8.7¡2.4 8.9¡1.7
REM (% of TST) 9.8¡1.9 11.0¡2.9 11.5¡3.6 9.5¡2.6
REM latency min 108¡30 102¡43 126¡22 104¡28
Arousals index 12.0¡1.8 11.2¡0.8 12.7¡1.3 10.7¡2.1
Data are presented as mean¡SEM unless otherwise stated; TST: total sleep time; REM: rapid eye movement; All p-values of EE versus controls, and
basal versus after oxygen are nonsignificant.
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of nocturnal desaturation was the same for EE and controls,
EE subjects, who had lower Sa,O2 during the day, maintained
a lower Sa,O2 during the night. This difference was small in
absolute terms, but very consistent and prolonged during the
entire period of the night, and, in addition, it allowed the EE
group to spend a substantial period of the night with an Sa,O2
ofv80%. Transient oxygen desaturations, even reaching very
low values in Sa,O2, are not considered an important stimulus
for the production of erythropoietin, whereas clinical condi-
tions such as chronic obstructive pulmonary diseases and
chronic respiratory failure, characterised by stable and
prolonged hypoxaemia may be associated with polycythaemia
[27]. Therefore, it is likely that the percentage of sleep time
spent below a specific given level of Sa,O2 may be a deter-
minant of the haematopoietic response to hypoxia, even in
the absence of transient dramatic desaturations.
The authors found that EE patients spent one-half of the
night with an Sa,O2 in the range of 81–85%, and 38% of the
night in the range of 76–80%, whereas the healthy controls
spent most of the time with an Sa,O2 ofw81%. This points to
a possible Sa,O2 cut-off value of y80%, below which the
haematopoiesis may be stimulated. The presence of a thresh-
old of 80% Sa,O2 for the stimulation of erythropoietin
has been clearly documented previously [28]. Therefore, it is
possible that a mean reduction of 3–4% in nocturnal Sa,O2,
which has no effect in normal subjects, may drag patients with
EE that have lower diurnal Sa,O2 below a value that is critical
for erythropoiesis. This exactly crosses the difference between
the controls and EE subjects (fig. 1), and may thus explain at
least in part why, even in the absence of major respiratory
disorders some subjects develop polycythaemia, while others
do not, despite intergroup small differences in Sa,O2. At an
altitute of 3,100 m (Leadville, Colorado) and at 3,658 m
(Lhasa), it has been found that nocturnal hypoxaemia in
polycythaemic subjects is more marked compared with the
EE group (although polycythaemia is less severe at lower
altitude) [6, 7]. One possible explanation is that there may be
differences between ethnic groups. It is also possible that
the different altitude at which these studies were performed
may have determined these different results. While at lower
altitude a more severe SDB is necessary in order to induce
excessive polycythaemia, at higher altitude even a mild SDB
could induce moderate/severe polycythaemia, whereas a more
severe SDB could be incompatible with life.
The finding that SDB, though not severe, occurs in the
Andean population at 4,380 m is per se of interest. In fact
periodic breathing was not reported in a small group of
Himalayan Sherpas at an altitude ofw5,000 m [13]. If these
differences were confirmed by larger studies on both
populations, then nocturnal respiratory instability in the
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Fig. 1. – Time course of the nocturnal arterial oxygen saturation
(Sa,O2) in 10 subjects with excessive erythrocytosis (EE; $) and in 10
controls (#). Values are expressed as mean¡SEM. The Sa,O2
decreased significantly (pv0.01) from the awake state throughout the
sleep period in both EE and control groups. *: pv0.05 EE versus
control; **: pv0.01 EE versus control.
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Fig. 2. – Histogram showing the percentage of time spent in different
arterial oxygen saturation (Sa,O2) ranges for excessive erythrocytosis
patients (u) and controls (h). Groups were compared using a Mann-
Whitney U-test *: pv0.05 versus control; **: pv0.01 versus control.
Table 3. – Respiratory variables recorded during the first night (basal) and second night (after oxygen administration) in
excessive erythrocytosis EE and controls
Basal EE After oxygen EE Basal controls After oxygen controls p-value# p-value}
Awake VE L?min-1 12.9¡0.5 12.0¡0.5 NS
Awake ETCO2 mmHg 39.9¡1.0 38.3¡0.9 NS
Awake Sa,O2 % 83.7¡0.3 96.6¡0.4
z 85.6¡0.4 97.1¡0.5z v0.01 v0.01
Mean sleep Sa,O2 % 80.0¡0.8*** 80.3¡0.6 82.8¡0.5*** 83.6¡0.6 v0.05 NS
Lowest NREM Sa,O2 % 69.3¡2.7 68.3¡4.1 74.8¡1.0 74.7¡2.1 NS NS
Lowest REM Sa,O2 % 71¡2.9 71.8¡1.3 78.5¡1.2 78.8¡1.3 NS NS
AHI 10.0¡4.5 13.2¡7.0 8.7¡2.7 7.0¡2.0 NS NS
Mean duration of the apnoea /hypopnea s 24.2¡1.5 19.5¡1.7 20.3¡1.4 20.8¡0.9 NS NS
DSa,O2 % 5.4¡0.6 4.5¡0.6 4.6¡0.2 5.0¡0.2 NS NS
Data are presented as mean¡SEM unless otherwise stated; V9E: minute ventilation; ETCO2: end-tidal carbon dioxide; Sa,O2: arterial oxygen
satruration; REM: rapid eye movement; NREM: non-REM; AHI: apnoea/hypopnoea index; #: EE versus controls; }: basal control versus after
oxygen control;z: Sa,O2 during oxygen administration; NS: nonsignificant; ***: pv0.001 versus awake Sa,O2.
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Andeans may be considered a sign of poor adaptation to
altitude.
Both hypoxia and hypocapnia have been suggested as the
stimuli that trigger and sustain periodic breathing at altitude
[29, 30]. In sea-level natives ascending to altitude, SDB
is related to an increased HVR [13, 14] but in long-term
residents at altitude the HVR is blunted [3, 31], therefore it is
likely that other mechanisms may determine the nocturnal
respiratory instability in these subjects. These findings
support the hypothesis that the fall in arterial carbon dioxide
tension (Pa,CO2) may be a determinant factor. The AHI did
not correlate with basal ETCO2, in agreement with a previous
report [32] but correlated significantly with the HCVR. Since
a fall in Pa,CO2 below the apnoeic threshold depends on the
individual chemoreflex sensitivity, it is not surprising that the
AHI correlated with HCVR rather than with the ETCO2 level
itself. The concept that a high gain of central chemoreflex
response may lead to nocturnal periodic breathing has been
evidenced from many studies in animal and humans [29].
Briefly a low ETCO2 at basal condition may induce hyper-
ventilation with further decrease in CO2 below the apnoeic
threshold. The hyperventilation that occurs after each apnoea
further decreases the CO2 level triggering the next apnoea
and finally leading to a vicious circle. In patients with high
hypercapnic chemoreflex sensitivity these responses are
enhanced and apnoeas more likely to occur. This mechanism
is similar to what is shown at sea level in patients with chro-
nic heart failure experiencing nocturnal (and also diurnal)
periodic breathing; in addition, for these patients a clear
correlation has been shown between HCVR and SDB [33].
Despite this, a significant difference in HCVR was not
found in the two groups, in agreement with a recent study
[34], and with the rest of the literature. This suggests that this
factor may be able to explain the occurrence of sleep
abnormalities (which in fact were present in both EE and
controls to a similar extent), as it does in some patients at
sea level, but it does not necessarily play a partial role in the
origin of EE, whose cause is probably more related to the
lower Sa,O2. The lack of difference in HVR in the two groups
could be due to the relatively small number of subjects
studied, but again a normal or slightly reduced HVR may
not be necessarily the cause of the reduced Sa,O2. A depressed
HVR is a common finding in Andean natives living at high
altitude, regardless of the presence of EE [4, 16, 31], and even
recent studies confirmed the presence of very small differences
between these two groups of subjects [16]. The age of the
subjects also has some influence in the occurrence of
nocturnal respiratory instability as a slight but significant
positive correlation with the AHI was found. There is some
evidence that age can be a risk factor for nocturnal periodic
breathing also in lowlanders at sea level in the presence of
some pathological conditions [35].
All sleep variables were similar in the two groups and this
is in agreement with data reported at the same [11, 12] or at
a lower altitude [6]. In contrast, lowlanders undergo profound
changes in sleep pattern during the first days after ascending
to altitude, then improve with acclimatisation [8, 36]. Taken
together these observations suggest that sleep is a physiolo-
gical variable characterised by a fairly rapid adaptation to the
environmental conditions and is not negatively influenced by
chronic exposure to altitude.
This study indicates that Andean natives, with or without
excessive erythrocytosis, undergo mild respiratory disorders
during sleep, and that subjects with excessive erythrocytosis
have a slightly (but highly significant) lower nocturnal arterial
oxygen saturation and spend more time than controls with an
arterial oxygen saturation below 80% during the night. Since
an arterial oxygen saturation of 80% has been previously
identified as a threshold for erythropoiesis, further studies are
needed to establish whether or not a link exists between these
changes in nocturnal arterial oxygen saturation and excessive
erythrocytosis.
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